Newsweek, today:
This week, Keira Bell etched her name into history. Her legal victory in the British High Court of Justice on Tuesday marked the first time a neutral tribunal has examined protocols for transgender medicine now provided to minors across the West. The court, rather obviously, was appalled.
Bell, now 23, struggled in adolescence. At 14, the daughter of an alcoholic single mother was lonely, anxious and depressed, according to court documents. Always uncomfortable with her femininity, she began spending a lot of time online where she discovered trans influencers and decided she, too, was transgender.
By 15, she was referred to Britain's Gender Identity Development Service, England's national gender clinic, where a few cursory appointments led to a prescription for puberty blockers —^medications that shut down the part of a pituitary that stimulates normal puberty. From there^, she proceeded through a typical medical regimen for teen girls who identify as transgender: cross-sex hormones (testosterone), and then double mastectomy. By the time she had reached her twenties, she had a deep voice, a male torso, an impressive beard, masculinized facial features and male swagger. But the changes didn't satisfy. She began to "nitpick" her appearance, noticing her hands were smaller than a man's would be and she had a woman's height. In her twenties, she realized that her physical transition had not made her any happier; the peace she had sought, still out of reach.
"There was nothing wrong with my body, I was just lost and without proper support," she recently told Tribuna Feminista. "Transition gave me the facility to hide from myself even more than before. It was a temporary fix, if that."
She quit the testosterone, resumed living as a woman and sued the national clinic, petitioning for judicial review of the "affirmative" medical process that she claims provides no real safeguard for confused adolescents. The court seems to have agreed. Its decision was narrow: Minors under 16 do not have capacity to give "informed consent" to highly experimental and risky hormonal treatments that put their future fertility and sexual function at risk.
The court's careful review of the clinic's "affirmation model," which directs therapists and doctors to agree with the patient's self-diagnosis of "gender dysphoria"—revealed a system recklessly unmoored from the cautious, evidence-based approach that characterizes other areas of medicine. Transgender medicine for minors is dominated by nostrums: puberty blockers are a mere "pause button" on puberty; "kids know who they are"; "affirmation prevents suicide." Each of these is at best, wishful thinking—and at worst, a lie.